# US 2006/0068416 A1 · Devices coated with substances which mediate the adhesion of biological material

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0068416 A1
- Document ID: US20060068416A1
- Status: Published application
- Kind: A1
- Application number: 11/151,123
- Filed: 2005-06-13
- Published: 2006-03-30
- Earliest claimed: 2002-12-17
- Assignees: Eberhard-Karls-Universitaet Tuebingen Universitaetsklinikum
- Inventors: Hermann Schluesener; Hans-Peter Wendel
- Web page: https://patentgrep.com/patent/US20060068416A1

## CPC

- G01N 33/56966: {Animal cells}
- C12N 15/115: Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers}
- G01N 33/5308: {for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites}
- C12N 2310/16: Aptamers
- C12N 2310/351: Conjugate
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Devices having at least one surface which comes into contact with tissues and/or fluids of the human or animal body. These surfaces are at least partially coated with aptamers, which mediate the adhesion of biological material.

## Claims

### Claim 1

A device comprising at least one surface which comes into contact with tissues and/or fluids of the human or animal body and which is at least partially coated with substances which mediate the adhesion of biological material, wherein the substances are aptamers.

### Claim 2 (depends on 1)

The device as claimed in claim 1, wherein the aptamers are nucleic acid molecules which comprise at least one of the sequences SEQ ID No. 1 to SEQ ID No. 17 from the enclosed sequence listing.

### Claim 3 (depends on 1)

The device as claimed in claim 1, wherein the aptamers are nucleic acid molecules having at least one of the nucleotide sequences SEQ ID No. 1 to SEQ ID No. 17 from the enclosed sequence listing.

### Claim 4 (depends on 1)

The device as claimed in claim 1, wherein the aptamers are attached to the surface directly and/or by way of a linker molecule.

### Claim 5 (depends on 4)

The device as claimed in claim 4, wherein the linker molecule is N-succinimidyl-3-(2-pyridyldithio)propionate and/or a PEG block copolymer.

### Claim 6 (depends on 1)

The device as claimed in claim 1, wherein the biological material comprises cells which are selected from the group consisting of: stem cells, epithelial cells, endothelial cells, muscle cells, fibroblasts, osteoblasts, keratinocytes, astrocytes, retinocytes, Langerhans' cells, hepatocytes, cardiomyocytes, chondrocytes and chondroblasts and their precursor cells.

### Claim 7 (depends on 1)

The device as claimed in claim 1, wherein the biological material comprises proteins which are selected from the group consisting of: plasma proteins, membrane proteins, receptor proteins, integrins, enzymes, transducers, signal substances and messenger substances, and fragments thereof.

### Claim 8 (depends on 7)

The device as claimed in claim 7, wherein the proteins are selected from the group consisting of: fibronectin, laminin, vitronectin, thrombomodulin, high molecular weight kininogen, AT-III, C1-esterase-INH, complement factor H, plasminogen, VEGFR-1, VEGFR-2 (KDR), Tie-2, CD133, CD43, and fragments thereof.

### Claim 9 (depends on 1)

The device as claimed in claim 1, further comprising growth factors.

### Claim 10 (depends on 9)

The device as claimed in claim 9, wherein the growth factors are selected from the group consisting of: platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), colony-stimulating factor (CSF), epidermal growth factor (EGF), nerve growth factor (NGF), fibroblast growth factor (FGF) and growth factors from the transforming growth factor (TGF) superfamily.

### Claim 11 (depends on 1)

The device as claimed in claim 1, wherein the aptamers exhibit an enzymic activity.

### Claim 12 (depends on 11)

The device as claimed in claim 11, wherein the aptamers exhibit a DNAzyme activity.

### Claim 13 (depends on 1)

The device as claimed in claim 1, wherein the surface comprises a material which is selected from the group consisting of: polytetrafluoroethylene, polystyrene, polyurethane, polyester, polylactide, polyglycolic acid, polysulfone, polypropylene, polyethylene, polycarbonate, polyvinyl chloride, polyvinyl difluoride, polymethyl methacrylate, polyethylene terephthalate, ePTFT, texin (polyether-polyurethane) and copolymers thereof, nylon, silanized glass, ceramics, metals, and mixtures thereof.

### Claim 14 (depends on 1)

The device as claimed in claim 1, wherein the device is an implant.

### Claim 15

A nucleic acid molecule which comprises at least one of the nucleotide sequences SEQ ID No. 1 to SEQ ID No. 17 from the enclosed sequence listing.

### Claim 16 (depends on 15)

A nucleic acid molecule as claimed in claim 15, wherein the molecule is coupled to at least one of a diagnostic agent and a therapeutic agent.

### Claim 17

A method for producing devices comprising at least one surface which comes into contact with tissues. and/or fluids of the human or animal body and which is at least partially coated with substances which mediate the adhesion of biological material, comprising the following steps:
a) providing aptamers which mediate the adhesion of biological material,
b) binding the aptamers from step a) to the surface of a device.

### Claim 18 (depends on 17)

The method as claimed in claim 17, wherein the aptamers employed are nucleic acid molecules which comprise at least one of the nucleotide sequences SEQ ID No. 1 to SEQ ID No. 17 from the enclosed sequence listing.

### Claim 19 (depends on 18)

The method as claimed in claim 18, wherein the aptamers employed are nucleic acid molecules having at least one of the nucleotide sequences SEQ ID No. 1 to SEQ ID No. 17 from the enclosed sequence listing.

### Claim 20 (depends on 1)

The device as claimed in claim 1, wherein the surface comprises titanium.
